Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
General Counsel and CCO
-
Stock Symbol
-
ATHA on Nasdaq
Mark Worthington - trading volume in the past year for Athira Pharma, Inc.
Holdings reported by Mark Worthington for Athira Pharma, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
83.7K |
$47.1K |
$0.56 |
Jan 2, 2025 |
Direct |
|
|
| Restricted Stock Units |
57.3K |
$32.2K |
$0.56 |
Mar 3, 2025 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
85.9K |
|
|
Mar 3, 2025 |
Direct |
Common Stock |
|
Transactions reported by Mark Worthington for Athira Pharma, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.